ALEC (STOCKS)
Alector, Inc. Common Stock
$2.079900
-0.070100 (-3.26%)
Prev close: $2.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arnon Rosenthal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $330.67M
- Employees
- 163
- P/E (TTM)
- -1.97
- P/B (TTM)
- -24.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
5
Buy
4
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.21 | $-0.23 | +0.0226 | +9.72% |
|
Mar 2026 (Q1)
|
$-0.21 | $-0.35 | +0.1397 | +39.95% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.39 | +0.0514 | +13.13% |
|
Sep 2025 (Q3)
|
$-0.34 | $-0.42 | +0.0757 | +18.21% |
Financial Statements
| Revenues | $13.86M |
| Benefits Costs and Expenses | $131.42M |
| Costs And Expenses | $131.42M |
| Operating Expenses | $140.35M |
| Depreciation and Amortization | $4.54M |
| Research and Development | $99.13M |
| Other Operating Expenses | $38.97M |
| Operating Income/Loss | -$126.49M |
| Income/Loss From Continuing Operations After Tax | -$117.85M |
| Income/Loss From Continuing Operations Before Tax | -$117.56M |
| Income Tax Expense/Benefit | $298.00K |
| Net Income/Loss | -$117.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$117.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$117.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.10 |
| Diluted Earnings Per Share | -$1.10 |
| Basic Average Shares | 326,609,846 |
| Diluted Average Shares | 326,609,846 |
| Assets | $202.86M |
| Current Assets | $180.09M |
| Noncurrent Assets | $22.77M |
| Fixed Assets | $8.91M |
| Other Non-current Assets | $13.86M |
| Liabilities | $212.83M |
| Current Liabilities | $34.24M |
| Accounts Payable | $2.28M |
| Other Current Liabilities | $31.95M |
| Noncurrent Liabilities | $178.59M |
| Equity | -$9.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$9.97M |
| Liabilities And Equity | $202.86M |
| Net Cash Flow From Operating Activities | -$158.23M |
| Net Cash Flow From Operating Activities, Continuing | -$158.23M |
| Net Cash Flow From Investing Activities | $153.21M |
| Net Cash Flow From Investing Activities, Continuing | $153.21M |
| Net Cash Flow From Financing Activities | $20.17M |
| Net Cash Flow From Financing Activities, Continuing | $20.17M |
| Net Cash Flow | $15.14M |
| Net Cash Flow, Continuing | $15.14M |
| Comprehensive Income/Loss | -$117.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$118.08M |
| Other Comprehensive Income/Loss | -$57.61M |
| Other Comprehensive Income/Loss Attributable To Parent | -$222.00K |